组成图示
示意图生成中
传感器类型
—
检测对象
—
检测原理
—
检测灵敏度
—
效应效果
—
传感器的构成
—
中文摘要
—
英文摘要
Postoperative management of osteoporotic vertebral compression fracture (OVCF) remains challenging because conventional bone mineral density (BMD) and imaging assessments are intrinsically delayed, while bone turnover markers (BTMs) that reflect real-time remodeling dynamics are difficult to measure frequently in routine care. In parallel, commonly used anti-osteoporotic medications may be limited by delayed onset of measurable response and concerns regarding long-term tolerability in certain populations. This article is a narrative review and conceptual perspective that synthesizes recent advances in biosensor-enabled point-of-care testing-highlighting organic optoelectrochemical transistors (OPECT)-and mechanistic pharmacology evidence for kidney-tonifying and blood-activating traditional Chinese medicine (TCM) formulas. On this basis, we propose a closed-loop framework that links high-frequency BTM monitoring to biomarker-informed optimization of postoperative integrative management. Importantly, this work does not report original clinical implementation data; the proposed framework is intended to guide future translational research, standardization, and prospective clinical validation.